Scientific article
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
ContributorsPhillips, Andrew N; Venter, Francois; Havlir, Diane; Pozniak, Anton; Kuritzkes, Daniel; Wensing, Annemarie; Lundgren, Jens D; De Luca, Andrea; Pillay, Deenan; Mellors, John; Cambiano, Valentina; Bansi-Matharu, Loveleen; Nakagawa, Fumiyo; Kalua, Thokozani; Jahn, Andreas; Apollo, Tsitsi; Mugurungi, Owen; Clayden, Polly; Gupta, Ravindra K; Barnabas, Ruanne; Revill, Paul; Cohn, Jennifer; Bertagnolio, Silvia; Calmy, Alexandra
Published inThe lancet. HIV, vol. 6, no. 2, p. e116-e127
Publication date2019-02
Affiliation entities
Research groups
Citation (ISO format)
PHILLIPS, Andrew N et al. Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study. In: The lancet. HIV, 2019, vol. 6, n° 2, p. e116–e127. doi: 10.1016/s2352-3018(18)30317-5
Main files (1)
Article (Published version)
Secondary files (1)
Supplemental data
Identifiers
- PID : unige:173249
- DOI : 10.1016/s2352-3018(18)30317-5
- PMID : 30503325
Additional URL for this publicationhttps://linkinghub.elsevier.com/retrieve/pii/S2352301818303175
Journal ISSN2352-3018
